Insider Transactions in Q3 2022 at Cytom X Therapeutics, Inc. (CTMX)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 20
2022
|
Amy C. Peterson EVP, Chief Development Officer |
SELL
Open market or private sale
|
Direct |
7,463
-10.64%
|
$7,463
$1.42 P/Share
|
|
Jul 20
2022
|
Jeffrey B Landau Chief Business Officer |
SELL
Open market or private sale
|
Direct |
4,206
-12.04%
|
$4,206
$1.42 P/Share
|
|
Jul 20
2022
|
Sean A. Mc Carthy CEO |
SELL
Open market or private sale
|
Direct |
14,911
-4.88%
|
$14,911
$1.42 P/Share
|
|
Jul 20
2022
|
Lloyd A Rowland General Counsel |
SELL
Open market or private sale
|
Direct |
5,602
-11.37%
|
$5,602
$1.42 P/Share
|
|
Jul 20
2022
|
Alison L. Hannah Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
5,602
-14.94%
|
$5,602
$1.42 P/Share
|
|
Jul 20
2022
|
Carlos Campoy Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
3,949
-8.99%
|
$3,949
$1.42 P/Share
|
|
Jul 19
2022
|
Amy C. Peterson EVP, Chief Development Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,000
+22.18%
|
-
|
|
Jul 19
2022
|
Jeffrey B Landau Chief Business Officer |
BUY
Grant, award, or other acquisition
|
Direct |
11,250
+24.36%
|
-
|
|
Jul 19
2022
|
Sean A. Mc Carthy CEO |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+11.57%
|
-
|
|
Jul 19
2022
|
Lloyd A Rowland General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+23.33%
|
-
|
|
Jul 19
2022
|
Alison L. Hannah Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+28.57%
|
-
|
|
Jul 19
2022
|
Carlos Campoy Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+25.46%
|
-
|